Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Net Income towards Common Stockholders (2020 - 2024)

Agilon Health's Net Income towards Common Stockholders history spans 5 years, with the latest figure at -$1.2 million for Q3 2024.

  • For Q3 2024, Net Income towards Common Stockholders rose 87.47% year-over-year to -$1.2 million; the TTM value through Jun 2025 reached -$1.2 million, up 98.39%, while the annual FY2025 figure was $14.0 million, 259.76% up from the prior year.
  • Net Income towards Common Stockholders reached -$1.2 million in Q3 2024 per AGL's latest filing, down from -$518000.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $12.2 million in Q4 2020 to a low of -$63.3 million in Q4 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$5.1 million, with a median of -$647500.0 recorded in 2022.
  • The largest YoY upside for Net Income towards Common Stockholders was 1300.47% in 2023 against a maximum downside of 11942.78% in 2023.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $12.2 million in 2020, then tumbled by 273.35% to -$21.1 million in 2021, then soared by 97.51% to -$526000.0 in 2022, then crashed by 11942.78% to -$63.3 million in 2023, then soared by 98.13% to -$1.2 million in 2024.
  • Per Business Quant, the three most recent readings for AGL's Net Income towards Common Stockholders are -$1.2 million (Q3 2024), -$518000.0 (Q1 2024), and -$63.3 million (Q4 2023).